|
|
|
Insider
Information: |
Boger Joshua S |
Relationship: |
Director, 10% Owner |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
500,905 |
|
Indirect Shares
|
918,262 |
|
|
Direct
Value |
$132,785,738 |
|
|
Indirect Value
|
$36,503,325 |
|
|
Total
Shares |
1,419,167 |
|
|
Total
Value |
$169,289,063 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2017-06-08 |
284,088 |
2017-06-08 |
77,811 |
Premium* |
|
Cervomed Ord Shs |
CRVO |
Director, 10% Owner |
2024-02-26 |
216,817 |
2024-02-26 |
840,451 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
762 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 29 of 31
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-03 |
4 |
AS |
$100.09 |
$652,665 |
D/D |
(6,500) |
268,225 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-03 |
4 |
OE |
$36.30 |
$235,950 |
D/D |
6,500 |
274,725 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-10 |
4 |
AS |
$100.38 |
$60,420 |
I/I |
(600) |
81,600 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-10 |
4 |
AS |
$99.96 |
$651,292 |
D/D |
(6,500) |
268,225 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-10 |
4 |
OE |
$36.30 |
$235,950 |
D/D |
6,500 |
274,725 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-11 |
4 |
AS |
$100.19 |
$90,171 |
I/I |
(900) |
80,700 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-17 |
4 |
OE |
$36.30 |
$235,950 |
D/D |
6,500 |
274,725 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-17 |
4 |
AS |
$99.36 |
$647,415 |
D/D |
(6,500) |
268,225 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-17 |
4 |
AS |
$100.03 |
$40,012 |
I/I |
(400) |
80,300 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-22 |
4 |
AS |
$100.73 |
$110,869 |
I/I |
(1,100) |
79,200 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-24 |
4 |
AS |
$96.73 |
$652,032 |
D/D |
(6,500) |
268,225 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-24 |
4 |
AS |
$100.02 |
$101,442 |
I/I |
(1,000) |
78,200 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-24 |
4 |
OE |
$36.30 |
$235,950 |
D/D |
6,500 |
274,725 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-31 |
4 |
OE |
$36.30 |
$235,950 |
D/D |
6,500 |
274,725 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-08-31 |
4 |
AS |
$94.53 |
$615,045 |
D/D |
(6,500) |
268,225 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-09-07 |
4 |
OE |
$36.30 |
$235,950 |
D/D |
6,500 |
274,725 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-09-07 |
4 |
AS |
$95.61 |
$621,795 |
D/D |
(6,500) |
268,225 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-09-14 |
4 |
AS |
$88.76 |
$600,387 |
D/D |
(6,500) |
268,225 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-09-14 |
4 |
OE |
$36.30 |
$235,950 |
D/D |
6,500 |
274,725 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-09-21 |
4 |
AS |
$89.73 |
$590,332 |
D/D |
(6,500) |
268,225 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-09-21 |
4 |
OE |
$36.30 |
$235,950 |
D/D |
6,500 |
274,725 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-09-28 |
4 |
OE |
$36.30 |
$235,950 |
D/D |
6,500 |
274,725 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-09-28 |
4 |
AS |
$87.56 |
$572,978 |
D/D |
(6,500) |
268,225 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-10-05 |
4 |
AS |
$86.68 |
$568,379 |
D/D |
(6,500) |
268,225 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2016-10-05 |
4 |
OE |
$36.30 |
$235,950 |
D/D |
6,500 |
274,725 |
0 |
- |
|
762 Records found
|
|
Page 29 of 31 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|